Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo-Controlled Study in Cat-Allergic Patients with Allergic Rhinitis Who Live with a Cat to Assess the Efficacy and Safety of Andi-Fel d 1 Antibodies during Natural Cat Exposure in the Home

Project: Research

Project Details

StatusFinished
Effective start/end date01/24/22 → 01/23/23

Funding

  • Regeneron Pharmaceuticals Incorporated: $866.60